Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T00100
(Former ID: TTDI01666)
|
|||||
Target Name |
Ubiquitin-activating enzyme (UBA)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 2 Clinical Trial Drugs | + | ||||
1 | MLN7243 | Drug Info | Phase 1 | Solid tumour/cancer | [2] | |
2 | TAK-243 | Drug Info | Phase 1 | Solid tumour/cancer | [3] | |
Mode of Action | [+] 2 Modes of Action | + | ||||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | MLN7243 | Drug Info | [1] | |||
Inhibitor | [+] 1 Inhibitor drugs | + | ||||
1 | TAK-243 | Drug Info | [3] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | National Cancer Institute Drug Dictionary (drug id 757275). | |||||
REF 2 | ClinicalTrials.gov (NCT02045095) A Phase 1, Dose Escalation Study of MLN7243 in Adult Patients With Advanced Solid Tumors. U.S. National Institutes of Health. | |||||
REF 3 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.